CY1116316T1 - Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα - Google Patents

Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα

Info

Publication number
CY1116316T1
CY1116316T1 CY20151100465T CY151100465T CY1116316T1 CY 1116316 T1 CY1116316 T1 CY 1116316T1 CY 20151100465 T CY20151100465 T CY 20151100465T CY 151100465 T CY151100465 T CY 151100465T CY 1116316 T1 CY1116316 T1 CY 1116316T1
Authority
CY
Cyprus
Prior art keywords
methods
present
compositions including
variety
antibodies
Prior art date
Application number
CY20151100465T
Other languages
English (en)
Inventor
Claude Yves Nicolau
Ruth Greferath
David Hickman
Original Assignee
Ac Immune Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/783,975 external-priority patent/US20040242845A1/en
Priority claimed from US10/958,211 external-priority patent/US8663650B2/en
Application filed by Ac Immune Sa filed Critical Ac Immune Sa
Publication of CY1116316T1 publication Critical patent/CY1116316T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6093—Synthetic polymers, e.g. polyethyleneglycol [PEG], Polymers or copolymers of (D) glutamate and (D) lysine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Abstract

Η παρούσα εφεύρεση περιλαμβάνει νέες συνθέσεις και μεθόδους προκλήσεως υψηλών ανοσολογικών αποκρίσεων, μεγάλης ειδικότητας που αποδίδουν αντισώματα ευαίσθητα από άποψη διαμορφώσεως. Αυτά τα αντισώματα αναγνωρίζουν συγκεκριμένους επιτόπους επί μίας μεγάλης ποικιλίας αντιγόνων που περιλαμβάνουν, αλλά όχι περιοριστικά, αμυλοειδή πρωτεΐνη, πρωτεΐνη πρίον, γλυκοπρωτεΐνη Ρ170· Οι νέες συνθέσεις της εφευρέσεως περιλαμβάνουν υπερμοριακά αντιγονικά μορφώματα που γενικά περιλαμβάνουν μία πεπτιδική αλληλουχία, ομοιοπολικά προσδεδεμένη σε πεγκυλιωμένη λυσίνη καταλήγοντας σε τροποποιημένη και ενισχυμένη πεπτιδική παρουσίαση. Η μοναδική μεθοδολογία τροποποιήσεως της παρούσας εφευρέσεως είναι εφαρμόσιμη σε μία ποικιλία πεπτιδίων και μπορεί τελικά να χρησιμοποιηθεί σε θεραπευτικές συστάσεις και εμβόλια για νόσους και διαταραχές όπως η νόσος Alzheimer.
CY20151100465T 2004-02-20 2015-05-25 Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα CY1116316T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/783,975 US20040242845A1 (en) 2003-02-21 2004-02-20 Methods and compositions comprising supramolecular antigenic constructs and antibodies elicited against them
US10/958,211 US8663650B2 (en) 2003-02-21 2004-10-04 Methods and compositions comprising supramolecular constructs
EP12153152.9A EP2465533B1 (en) 2004-02-20 2005-02-22 Methods and compositions comprising supramolecular constructs

Publications (1)

Publication Number Publication Date
CY1116316T1 true CY1116316T1 (el) 2017-02-08

Family

ID=46395388

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20151100465T CY1116316T1 (el) 2004-02-20 2015-05-25 Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα

Country Status (11)

Country Link
JP (1) JP4934433B2 (el)
KR (1) KR101277004B1 (el)
CY (1) CY1116316T1 (el)
DK (1) DK2465533T3 (el)
ES (2) ES2539262T3 (el)
HK (2) HK1130698A1 (el)
HR (1) HRP20150612T1 (el)
HU (1) HUE025186T2 (el)
PT (1) PT2465533E (el)
RS (1) RS54074B1 (el)
SI (1) SI2465533T1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010106127A2 (en) * 2009-03-18 2010-09-23 Ac Immune S.A. Method for therapeutic use
EP2632434A1 (en) * 2010-10-26 2013-09-04 AC Immune S.A. Liposome-based construct comprising a peptide modified through hydrophobic moieties

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187335B1 (en) * 1997-12-31 2001-02-13 Orasomal Technologies, Inc. Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
WO1999041279A2 (en) 1998-02-13 1999-08-19 Arch Development Corporation Methods and compositions comprising the use of blocked b-amyloid peptide
EP2070968A3 (en) * 1999-12-22 2013-07-24 Nektar Therapeutics Method for the Preparation of 1-Benzotriazolyl Carbonate Esters of Poly(ethylene glycol)

Also Published As

Publication number Publication date
HK1172260A1 (en) 2013-04-19
KR101277004B1 (ko) 2013-06-24
SI2465533T1 (sl) 2015-07-31
HUE025186T2 (en) 2016-02-29
DK2465533T3 (en) 2015-04-20
HRP20150612T1 (hr) 2015-07-03
JP2007527870A (ja) 2007-10-04
PT2465533E (pt) 2015-06-24
ES2539262T3 (es) 2015-06-29
JP4934433B2 (ja) 2012-05-16
ES2385226T9 (es) 2013-10-10
ES2385226T3 (es) 2012-07-19
HK1130698A1 (en) 2010-01-08
KR20120097546A (ko) 2012-09-04
RS54074B1 (en) 2015-10-30

Similar Documents

Publication Publication Date Title
ATE552848T1 (de) Verfahren und zusammensetzungen mit supramolekularen konstrukten
CY1115014T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΕΙΔΙΚΑ ΓΙΑ Αβ1-42 ΜΕ ΘΕΡΑΠΕΥΤΙΚΕΣ ΙΔΙΟΤΗΤΕΣ
CY1119792T1 (el) Βασισμενη σε πρωτεϊνες θεραπεια και διαγνωση tau-διαμεσολαβουμενης παθολογιας σε νοσο του alzheimer
DE60221665D1 (de) Impfstoff zur verhütung und behanldung von alzheimer-demenz und von amyloid-bezogenen krankheiten
CY1118037T1 (el) Αντισωματα εναντι του αβητα και h χρηση τους
EA200601671A1 (ru) Идентификация собственных и чужеродных антигенов, вовлечённых в аутоиммунные заболевания
NO20022531L (no) Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
ATE510851T1 (de) Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose
CY1117643T1 (el) Συνθεσεις νεϊσσεριακου εμβολιου που περιλαμβανουν συνδυασμο αντιγονων
CY1119376T1 (el) Αντισωματα ειδικα για τη μορφη πρωτοϊνιδιου της βητα-αμυλοειδους πρωτεϊνης
AT500379B1 (de) Tau-proteine
CY1110634T1 (el) Μεθοδοι προληψης και θεραπειας της νοσου του αλτσχαϊμερ (ad)
EA200700136A1 (ru) Анти-cd154-антитела
CY1115316T1 (el) Πεπτιδια για τη θεραπευτικη αγωγη βητα-αμυλοειδωσεων
AR107290A1 (es) ANTICUERPOS PEPTÍDICOS b AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS
AU2003270643A8 (en) Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
DK1362109T3 (da) Rekombinante oligomere protein-komplekser med foröget immunogent potentiale
EP2403871A4 (en) SPECIFIC ANTIBODIES AND EPITOPES OF A PRION PROTEIN
CY1116316T1 (el) Μεθοδοι και συνθεσεις που περιλαμβανουν υπερμοριακα μορφωματα
HK1088909A1 (en) Peptide-based immunization therapy for treatment of atherosclerosis
ATE530565T1 (de) Impfstoff zur prävention und behandlung von progressiver atrophischer rhinitis in schweinen
ATE450272T1 (de) Rekombinantes adenylat-cyclase-toxin von bordetella induziert t-zell-antworten gegen tumorale antigene
DK1019085T3 (da) Ikke-anafylaktiske former for allergener og deres anvendelse
MX2022011199A (es) Peptidos ciclicos.
AR037939A1 (es) Receptor novedoso acoplado a la proteina g, gave7